Tag: COVID-19

Fox News Flash top headlines for July 22 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. An advisory panel to the Centers for Disease Control and Prevention (CDC) said the benefits of COVID-19 vaccines “far outweigh” potential risks amid an ongoing review of reports of a rare nerve disorder in

A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects. The research, published June 15 in Science Immunology,

Fox News Flash top headlines for June 15 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. A small study offers the first hint that an extra dose of COVID-19 vaccines just might give some organ transplant recipients a needed boost in protection. Even as most vaccinated people celebrate a return

Fox News Flash top headlines for June 10 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The first dose of AstraZeneca’s COVID-19 vaccine was associated with a “very small” increased risk of bleeding and other rare blood disorders, researchers say. Findings published in Nature Medicine on Wednesday stemmed from a

NEW YORK (Reuters Health) – Denmark saw a drastic reduction in hospital admissions for diseases other than COVID-19 during the national lockdowns last year, and this decrease tended to be accompanied by increased death rates among those hospitalized, according to new findings. The reasons behind the higher mortality are complex, however, Dr. Jacob Bodilsen of

NEW YORK (Reuters Health) – A meta-analysis of SARS-CoV-2 epitopes targeted by T cells in convalescent patients identified 20 that are prevalent in multiple cohorts, and potentially relevant to vaccine development and diagnostics, researchers say. “Increasing evidence suggests T-cell immunity to be an important factor in protecting against severe COVID-19 disease,” Drs. Matthew McKay and

STOCKHOLM (Reuters) – Sweden’s centre-left, minority government failed in several aspects of its handling of the COVID-19 pandemic, parliament’s constitutional committee said on Thursday. The government was slow to put in place a testing and tracing system, failed to protect the elderly, and there was a lack of clear lines of responsibility between national and

In an analysis of patients on hemodialysis in New York City, there were substantial racial/ethnic disparities in COVID-19 rates that were not explained by neighborhood social vulnerability. The findings appear in an upcoming issue of JASN. The COVID-19 pandemic has disproportionately affected socially disadvantaged groups, including Black and Hispanic individuals, those with limited English proficiency,

NEW YORK (Reuters Health) – Hyperpolarized xenon-129 MRI (XeMRI) can detect lung abnormalities in patients with breathlessness following COVID-19 pneumonia that are not evident on routine tests, according to a preliminary report from researchers in the U.K. In nine patients evaluated at three months or longer after hospital discharge for COVID-19, XeMRI showed alveolar-capillary diffusion

Individuals with genetic high cholesterol, heart disease, or both and who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer outcomes if a person with genetic high cholesterol—called familial hypercholesterolemia (FH)—contracts COVID-19, this study from the FH Foundation’s national healthcare database

BRASILIA (Reuters) – Almost half of the more than 3.4 million COVID-19 deaths reported so far in the world have occurred in the Americas, but the real numbers may be higher, the Pan American Health Organization (PAHO) warned on Wednesday. Last week, the World Health Organization said COVID deaths were being significantly undercounted worldwide. “According

Within the next decade, the novel coronavirus responsible for COVID-19 could become little more than a nuisance, causing no more than common cold-like coughs and sniffles. That possible future is predicted by mathematical models that incorporate lessons learned from the current pandemic on how our body’s immunity changes over time. Scientists at the University of

The World Health Organization said Wednesday that a variant of COVID-19 behind the acceleration of India’s explosive outbreak has been found in dozens of countries all over the world. The UN health agency said the B.1.617 variant of COVID-19, first found in India in October, had been detected in more than 4,500 samples uploaded to

BENGALURU, India — Since India opened vaccinations to all adults this month, hoping to tame a disastrous coronavirus surge sweeping across the country, the pace of administering the shots has dropped with states saying they only have limited stock to give out. Cases meanwhile are still rising at record pace in the world’s second-most populous

Many of those infected with the COVID-19 virus were able to make a full recovery, while some never even felt the symptoms at all and only learned of their infection through testing positive, much to their surprise. Others, tragically, lost their lives, with more than 588,000 people in the U.S. dying from COVID, per NBC

MRNA VS. CONVENTIONAL VACCINES Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron Working Together to Empower Women Reducing Health Disparities in Latino Communities Pfizer Women’s Resource Group Universal vs. Single Payer Healthcare Hear from Pfizer CEO and President Albert Bourla about the company’s planned response to the humanitarian crisis facing India as it battles

MRNA VS. CONVENTIONAL VACCINES Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron Working Together to Empower Women Reducing Health Disparities in Latino Communities Pfizer Women’s Resource Group Universal vs. Single Payer Healthcare Hear from Pfizer CEO and President Albert Bourla about the company’s planned response to the humanitarian crisis facing India as it battles

Moderna says a third booster shot for its two-dose COVID-19 vaccine will be available in the United States by the fall. The announcement was made by company CEO Stéphane Bancel, CBS News reported. Studies show that the Moderna vaccine is more than 90 percent effective six months after the second dose, but it is unclear

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research

SYDNEY (Reuters) – Australia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation cancellations as authorities try to steady a bungled immunisation campaign. This week Australia abandoned a goal of vaccinating all of its nearly 26 million